These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 23058985)

  • 1. Beta-D-glucoside protects against advanced glycation end products (AGEs)-mediated diabetic responses by suppressing ERK and inducing PPAR gamma DNA binding.
    Mahali SK; Manna SK
    Biochem Pharmacol; 2012 Dec; 84(12):1681-90. PubMed ID: 23058985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced glycation end products induce lipogenesis: regulation by natural xanthone through inhibition of ERK and NF-κB.
    Mahali SK; Verma N; Manna SK
    J Cell Physiol; 2014 Dec; 229(12):1972-80. PubMed ID: 24733604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pioglitazone suppresses advanced glycation end product-induced expression of plasminogen activator inhibitor-1 in vascular smooth muscle cells.
    Yuan X; Liu N
    J Genet Genomics; 2011 May; 38(5):193-200. PubMed ID: 21621740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation end products downregulates peroxisome proliferator-activated receptor γ expression in cultured rabbit chondrocyte through MAPK pathway.
    Yang Q; Chen C; Wu S; Zhang Y; Mao X; Wang W
    Eur J Pharmacol; 2010 Dec; 649(1-3):108-14. PubMed ID: 20863825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosiglitazone prevents advanced glycation end products-induced renal toxicity likely through suppression of plasminogen activator inhibitor-1.
    Yu X; Li C; Li X; Cai L
    Toxicol Sci; 2007 Apr; 96(2):346-56. PubMed ID: 17264099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor gamma down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury model.
    Wang K; Zhou Z; Zhang M; Fan L; Forudi F; Zhou X; Qu W; Lincoff AM; Schmidt AM; Topol EJ; Penn MS
    J Pharmacol Exp Ther; 2006 Apr; 317(1):37-43. PubMed ID: 16368901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nifedipine inhibits advanced glycation end products (AGEs) and their receptor (RAGE) interaction-mediated proximal tubular cell injury via peroxisome proliferator-activated receptor-gamma activation.
    Matsui T; Yamagishi S; Takeuchi M; Ueda S; Fukami K; Okuda S
    Biochem Biophys Res Commun; 2010 Jul; 398(2):326-30. PubMed ID: 20599709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
    Lin MS; Chen WC; Bai X; Wang YD
    J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
    Chen ZY; Tseng CC
    Mol Pharmacol; 2005 Nov; 68(5):1203-13. PubMed ID: 16077033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-κB signaling pathway.
    Zhang HL; Xu M; Wei C; Qin AP; Liu CF; Hong LZ; Zhao XY; Liu J; Qin ZH
    Neuroscience; 2011 Mar; 176():381-95. PubMed ID: 21185913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis induced by troglitazone is both peroxisome proliferator-activated receptor-gamma- and ERK-dependent in human non-small lung cancer cells.
    Li M; Lee TW; Yim AP; Mok TS; Chen GG
    J Cell Physiol; 2006 Nov; 209(2):428-38. PubMed ID: 16883598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of ribosylated-BSA in regulating PC12 cell viability.
    Kuo TY; Huang CL; Yang JM; Huang WJ; Huang NK; Chen YW; Lin RJ; Yang YC
    Cell Biol Toxicol; 2012 Aug; 28(4):255-67. PubMed ID: 22543687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor (TGF)-beta1-induced human endometrial stromal cell decidualization through extracellular signal-regulated kinase and Smad activation in vitro: peroxisome proliferator-activated receptor gamma acts as a negative regulator of TGF-beta1.
    Chang HJ; Lee JH; Hwang KJ; Kim MR; Chang KH; Park DW; Min CK
    Fertil Steril; 2008 Oct; 90(4 Suppl):1357-65. PubMed ID: 18082740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARgamma-mediated advanced glycation end products regulation of neural stem cells.
    Wang SH; Sun ZL; Guo YJ; Yuan Y; Li L
    Mol Cell Endocrinol; 2009 Aug; 307(1-2):176-84. PubMed ID: 19524138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DHA inhibited AGEs-induced retinal microglia activation via suppression of the PPARγ/NFκB pathway and reduction of signal transducers in the AGEs/RAGE axis recruitment into lipid rafts.
    Wang L; Chen K; Liu K; Zhou Y; Zhang T; Wang B; Mi M
    Neurochem Res; 2015 Apr; 40(4):713-22. PubMed ID: 25596942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ellagic acid inhibits oxidized low-density lipoprotein (OxLDL)-induced metalloproteinase (MMP) expression by modulating the protein kinase C-α/extracellular signal-regulated kinase/peroxisome proliferator-activated receptor γ/nuclear factor-κB (PKC-α/ERK/PPAR-γ/NF-κB) signaling pathway in endothelial cells.
    Kuo MY; Ou HC; Lee WJ; Kuo WW; Hwang LL; Song TY; Huang CY; Chiu TH; Tsai KL; Tsai CS; Sheu WH
    J Agric Food Chem; 2011 May; 59(9):5100-8. PubMed ID: 21480623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of PPAR{gamma} by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR.
    Chen A; Xu J
    Am J Physiol Gastrointest Liver Physiol; 2005 Mar; 288(3):G447-56. PubMed ID: 15486348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetaldehyde inhibits PPARgamma via H2O2-mediated c-Abl activation in human hepatic stellate cells.
    Ceni E; Crabb DW; Foschi M; Mello T; Tarocchi M; Patussi V; Moraldi L; Moretti R; Milani S; Surrenti C; Galli A
    Gastroenterology; 2006 Oct; 131(4):1235-52. PubMed ID: 17030193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosiglitazone increases PPARgamma in renal tubular epithelial cells and protects against damage by hydrogen peroxide.
    Sommer M; Wolf G
    Am J Nephrol; 2007; 27(4):425-34. PubMed ID: 17622750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenic response of advanced glycation end products (AGEs) involves PPARgamma.
    Devi MS; Sudhakaran PR
    Indian J Biochem Biophys; 2012 Feb; 49(1):18-24. PubMed ID: 22435140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.